Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma

Authors:
  • SCS. Ch’NG
    S. Ch’NG

Abstract
No abstract available
Funding Information
  • National Health and Medical Research Council (2022/GNT2018514)
  • University of Sydney
  • Melanoma Institute Australia

This publication has 25 references indexed in Scilit: